6550--Cepheid Consumables at Overton Brooks VA Medical Center Amend 1

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

256-NETWORK CONTRACT OFFICE 16 (36C256)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25626Q0278

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Shreveport, Louisiana, UNITED STATES

SourceSAM
The Department of Veterans Affairs, through its 256-Network Contract Office 16, has issued a combined synopsis/solicitation for the procurement of Cepheid consumables to support the Overton Brooks VA Medical Center located in Shreveport, Louisiana. This procurement is classified under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is further identified by Product Service Code 6550, indicating a focus on medical and surgical instruments, equipment, and supplies. The primary objective of this solicitation is to secure a reliable supply of Cepheid consumables, which are essential for the medical center’s diagnostic operations. These consumables are critical components used in in-vitro diagnostic testing, supporting the facility’s mission to deliver high-quality healthcare services to veterans. The intended outcome is to ensure uninterrupted access to these specialized supplies, thereby maintaining the medical center’s diagnostic capabilities and overall operational readiness. This notice serves as Amendment 1 to the original solicitation. The amendment includes the posting of questions and answers received from potential offerors, as well as an updated solicitation document reflecting recent changes. Notably, the Federal Acquisition Regulation (FAR) clause 52.225-1, Buy American Supplies (OCT 2022), has been removed from the solicitation. Additionally, the Performance Work Statement (PWS) has been revised: Section 6, Customer Service, has been updated, and Section 16, "Availability of the Vendor," has been removed. These modifications clarify the expectations for vendor support and streamline the solicitation requirements. Interested contractors are required to submit their proposals by January 15, 2026, at 3:00 PM Central Standard Time. The procurement is being managed by T Miller, who serves as the primary point of contact and can be reached via email at [email protected] or by phone at 713-791-1414 x229073 for any solicitation-related inquiries. The solicitation is active and accessible through the SAM.gov portal, where six attachments provide additional details and supporting documentation. Contractors are encouraged to review all posted materials to ensure a comprehensive understanding of the requirements and to verify alignment with their capabilities in the manufacturing and supply of in-vitro diagnostic substances. This opportunity is particularly suited for vendors with experience in supplying specialized diagnostic consumables to federal healthcare facilities. The procurement does not specify any set-aside requirements or special considerations beyond the amendments noted, but contractors should ensure compliance with all updated solicitation terms and conditions. In summary, this procurement seeks to establish a dependable source for Cepheid consumables at the Overton Brooks VA Medical Center, supporting the facility’s ongoing commitment to veteran healthcare. Contractors with relevant expertise and capacity are invited to participate in this solicitation process.
Documents6